2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

Objective: To formulate evidence-based recommendations and overarching principles on the use of imaging in the clinical management of crystal-induced arthropathies (CiAs). Methods: An international task force of 25 rheumatologists, radiologists, methodologists, healthcare professionals and patient research partners from 11 countries was formed according to the EULAR standard operating procedures. Fourteen key questions on the role of imaging in the most common forms of CiA were generated. The CiA assessed included gout, calcium pyrophosphate deposition disease and basic calcium phosphate deposition disease. Imaging modalities included conventional radiography, ultrasound, CT and MRI. Experts applied research evidence obtained from four systematic literature reviews using MEDLINE, EMBASE and CENTRAL. Task force members provided level of agreement (LoA) anonymously by using a Numerical Rating Scale from 0 to 10. Results: Five overarching principles and 10 recommendations were developed encompassing the role of imaging in various aspects of patient management: making a diagnosis of CiA, monitoring inflammation and damage, predicting outcome, response to treatment, guided interventions and patient education. Overall, the LoA for the recommendations was high (8.46-9.92). Conclusions: These are the first recommendations that encompass the major forms of CiA and guide the use of common imaging modalities in this disease group in clinical practice

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

ObjectiveCalcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have developed the first-ever validated classification criteria for symptomatic CPPD disease.MethodsSupported by the ACR and EULAR, a multinational group of investigators followed established methodology to develop these disease classification criteria. The group generated lists of candidate items and refined their definitions, collected de-identified patient profiles, evaluated strengths of associations between candidate items and CPPD disease, developed a classification criteria framework, and used multi-criterion decision analysis to define criteria weights and a classification threshold score. The criteria were validated in an independent cohort.ResultsAmong patients with joint pain, swelling, or tenderness (entry criterion) whose symptoms are not fully explained by an alternative disease (exclusion criterion), the presence of crowned dens syndrome or calcium pyrophosphate crystals in synovial fluid are sufficient to classify a patient as having CPPD disease. In the absence of these findings, a score >56 points using weighted criteria, comprising clinical features, associated metabolic disorders, and results of laboratory and imaging investigations, can be used to classify as CPPD disease. These criteria had a sensitivity of 92.2% and specificity of 87.9% in the derivation cohort (190 CPPD cases, 148 mimickers), whereas sensitivity was 99.2% and specificity was 92.5% in the validation cohort (251 CPPD cases, 162 mimickers).ConclusionThe 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field

Study of bone composition and structural changes during femoral head osteonecrosis and etiopathogenic MRI correlations

La physiopathologie et l'évolution structurale de l'ostéonécrose de tête fémorale (ONTF) sont des processus encore largement méconnus. Les objectifs de cette thèse ont été de rechercher des modifications de composition et de structure de l'os trabéculaire et de l'os sous-chondral dans l'ONTF. Un travail préliminaire s'est intéressé aux modifications de composition osseuse en spectrométrie Raman induites par l'embaumement afin de déterminer les témoins les plus appropriés pour comparer les os pathologiques. Des tissus osseux fémoraux issus de 5 sujets anatomiques embaumés ont ainsi été comparés à ceux de 5 sujets anatomiques frais. Le premier travail sur l'ONTF a consisté à rechercher des modifications des paramètres physico-chimiques minéraux et organiques en spectrométrie Raman de l'os trabéculaire de tête fémorale chez 11 patients ayant une ONTF versus 11 sujets frais. Le second travail concernant l'ONTF a porté sur l'étude de l'os sous-chondral. Cette recherche a prévu l'inclusion de 15 patients ayant une ONTF à 15 patients ayant une coxarthrose nécessitant un remplacement prothétique. Une évaluation IRM avec séquences usuelles, séquences de perfusion et séquences DIXON était réalisée préalablement à la chirurgie. Après la chirurgie, l'ensemble de la tête fémorale était ensuite analysé en nano-scanner (nano-CT), puis des biopsies en zones d'intérêt ont été réalisées et analysées par histologie, nano-CT avec amplificateur de contraste et spectrométrie Raman.RésultatsLa composition des tissus osseux fémoraux des sujets anatomiques frais et embaumés différaient de manière significative sur les paramètres minéraux et organiques. La composition de l'os trabéculaire sur les zones d’intérêt ne différait pas entre les patients ayant une ONTF et le groupe de sujets anatomiques frais après ajustement sur l'âge. Le volume de nécrose définie en IRM par la zone en hyposignal T1 est corrélé au volume de nécrose incluant la zone sclérotique en nano-CT. Concernant l'os sous-chondral, les résultats préliminaires mettent en évidence des différences de composition minérale et organique en spectrométrie Raman au niveau de la plaque souschondrale entre les zones d’intérêt du groupe ONTF et avec le groupe coxarthrose. Les résultats préliminaires qualitatifs des biopsies en nano-CT et en histologie suggèrent que l'atteinte de la plaque sous-chondrale est prédominante sur celle de l'os trabéculaire souschondral. L’évaluation IRM (séquence DIXON) et en nano-CT de la richesse adipeuse suggère une relative pauvreté adipeuse de la tête fémorale mais une richesse excessive du col fémoral.Ce travail apporte des éléments supplémentaires suggérant que la désorganisation de l'os trabéculaire au cours de l'ONTF est une conséquence d'une atteinte massive de l'os sous-chondral.IntroductionThe pathophysiology and structural evolution of the osteonecrosis of the femoral head (ONFH) are poorly understood. The objectives of this thesis were to search for modifications of composition and structure of both the trabecular and the subchondral bone occurring during ONFH.MethodsA preliminary study looked into the potential modifications of bone composition induced by embalmment procedures using Raman spectroscopy in order to determine which controls are the most appropriate for comparisons with pathological bones. Femoral bones from 5 embalmed anatomical subjects were compared to femoral bones from 5 subjects that did not undergo any preservation procedure. The first work on ONFH addressed the potential modifications of trabecular bone mineral and organic physico-chemical parameters using Raman spectroscopy. The study included bone samples from femoral heads of 11 patients affected with ONFH and compared them to samples from 11 fresh anatomical subjects. The second study on ONFH addressed modifications of the subchondral bone. The study included 15 patients suffering from ONFH and 15 patients affected with hip osteoarthritis (OA) requiring joint prosthetic replacement. MRI examination that included standard medical sequences as well as experimental perfusion and DIXON sequences was performed prior to surgery. Once removed, the femoral heads were scanned using a nano-CT and samples of regions of interest were performed and analysed using histology, nano-CT with contrastenhancer marking and Raman spectroscopy.ResultsBone femoral mineral and organic composition was significantly altered in embalmed samples. Trabecular bone composition did not differ in any of the regions of interest inside the group of patients with ONFH nor in comparison with the control group of embalmed subjects after adjustment on age. The volume of the necrotic zone defined by the hypo-T1 MRI signal correlates to the volume including the sclerotic zone measured by nano-CT. Regarding the subchondral bone, preliminary results found differences of mineral and organic composition of the subchondral plate between zones of the ONFH group and with the OA group. Qualitative preliminary results from the study of biopsies analysed with the nano-CT and histology suggest that there are alterations of the subchondral plate and of the subchondral trabecular bone to a lesser extent. MRI examination with the DIXON sequence and nano-CT scans suggest that there is a decrease of the adipose content in the femoral head but an increase in the femoral neck in the ONFH group compared to the OA group.ConclusionThis work adds further evidence advocating that trabecular disorganization during ONFH is a consequence of massive alterations of the subchondral bone

Étude des modifications osseuses de composition et de structure au cours de l’ostéonécrose de tête fémorale et corrélations étiopathogéniques IRM

IntroductionThe pathophysiology and structural evolution of the osteonecrosis of the femoral head (ONFH) are poorly understood. The objectives of this thesis were to search for modifications of composition and structure of both the trabecular and the subchondral bone occurring during ONFH.MethodsA preliminary study looked into the potential modifications of bone composition induced by embalmment procedures using Raman spectroscopy in order to determine which controls are the most appropriate for comparisons with pathological bones. Femoral bones from 5 embalmed anatomical subjects were compared to femoral bones from 5 subjects that did not undergo any preservation procedure. The first work on ONFH addressed the potential modifications of trabecular bone mineral and organic physico-chemical parameters using Raman spectroscopy. The study included bone samples from femoral heads of 11 patients affected with ONFH and compared them to samples from 11 fresh anatomical subjects. The second study on ONFH addressed modifications of the subchondral bone. The study included 15 patients suffering from ONFH and 15 patients affected with hip osteoarthritis (OA) requiring joint prosthetic replacement. MRI examination that included standard medical sequences as well as experimental perfusion and DIXON sequences was performed prior to surgery. Once removed, the femoral heads were scanned using a nano-CT and samples of regions of interest were performed and analysed using histology, nano-CT with contrastenhancer marking and Raman spectroscopy.ResultsBone femoral mineral and organic composition was significantly altered in embalmed samples. Trabecular bone composition did not differ in any of the regions of interest inside the group of patients with ONFH nor in comparison with the control group of embalmed subjects after adjustment on age. The volume of the necrotic zone defined by the hypo-T1 MRI signal correlates to the volume including the sclerotic zone measured by nano-CT. Regarding the subchondral bone, preliminary results found differences of mineral and organic composition of the subchondral plate between zones of the ONFH group and with the OA group. Qualitative preliminary results from the study of biopsies analysed with the nano-CT and histology suggest that there are alterations of the subchondral plate and of the subchondral trabecular bone to a lesser extent. MRI examination with the DIXON sequence and nano-CT scans suggest that there is a decrease of the adipose content in the femoral head but an increase in the femoral neck in the ONFH group compared to the OA group.ConclusionThis work adds further evidence advocating that trabecular disorganization during ONFH is a consequence of massive alterations of the subchondral bone.La physiopathologie et l'évolution structurale de l'ostéonécrose de tête fémorale (ONTF) sont des processus encore largement méconnus. Les objectifs de cette thèse ont été de rechercher des modifications de composition et de structure de l'os trabéculaire et de l'os sous-chondral dans l'ONTF. Un travail préliminaire s'est intéressé aux modifications de composition osseuse en spectrométrie Raman induites par l'embaumement afin de déterminer les témoins les plus appropriés pour comparer les os pathologiques. Des tissus osseux fémoraux issus de 5 sujets anatomiques embaumés ont ainsi été comparés à ceux de 5 sujets anatomiques frais. Le premier travail sur l'ONTF a consisté à rechercher des modifications des paramètres physico-chimiques minéraux et organiques en spectrométrie Raman de l'os trabéculaire de tête fémorale chez 11 patients ayant une ONTF versus 11 sujets frais. Le second travail concernant l'ONTF a porté sur l'étude de l'os sous-chondral. Cette recherche a prévu l'inclusion de 15 patients ayant une ONTF à 15 patients ayant une coxarthrose nécessitant un remplacement prothétique. Une évaluation IRM avec séquences usuelles, séquences de perfusion et séquences DIXON était réalisée préalablement à la chirurgie. Après la chirurgie, l'ensemble de la tête fémorale était ensuite analysé en nano-scanner (nano-CT), puis des biopsies en zones d'intérêt ont été réalisées et analysées par histologie, nano-CT avec amplificateur de contraste et spectrométrie Raman.RésultatsLa composition des tissus osseux fémoraux des sujets anatomiques frais et embaumés différaient de manière significative sur les paramètres minéraux et organiques. La composition de l'os trabéculaire sur les zones d’intérêt ne différait pas entre les patients ayant une ONTF et le groupe de sujets anatomiques frais après ajustement sur l'âge. Le volume de nécrose définie en IRM par la zone en hyposignal T1 est corrélé au volume de nécrose incluant la zone sclérotique en nano-CT. Concernant l'os sous-chondral, les résultats préliminaires mettent en évidence des différences de composition minérale et organique en spectrométrie Raman au niveau de la plaque souschondrale entre les zones d’intérêt du groupe ONTF et avec le groupe coxarthrose. Les résultats préliminaires qualitatifs des biopsies en nano-CT et en histologie suggèrent que l'atteinte de la plaque sous-chondrale est prédominante sur celle de l'os trabéculaire souschondral. L’évaluation IRM (séquence DIXON) et en nano-CT de la richesse adipeuse suggère une relative pauvreté adipeuse de la tête fémorale mais une richesse excessive du col fémoral.Ce travail apporte des éléments supplémentaires suggérant que la désorganisation de l'os trabéculaire au cours de l'ONTF est une conséquence d'une atteinte massive de l'os sous-chondral

GOSPEL 4 - Patients with early onset gout develop earlier severe joint involvement and metabolic comorbid conditions

International audienc

Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval

International audienc

Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study

International audienceChoosing the subcutaneous (SC) route of administration of abatacept and tocilizumab is more cost-effective than the intravenous (IV) route. The objective of this study was to examine patients' reasons for choosing to keep with their IV infusions or to switch to subcutaneous SC injections. This study was based upon a self-administered questionnaire given to consecutive rheumatoid arthritis patients treated with abatacept or tocilizumab. Patients were asked to express their opinions concerning reasons explaining why they chose to keep the IV route or switch to the SC route. A total of 201 questionnaires completed by 127 patients treated by tocilizumab and 74 by abatacept were analysed. Overall, 45.8% of the patients chose to keep the IV route of administration. Another ongoing SC treatment was noted more often in patients choosing the SC route (15.9 versus 4.3%, p < 0.05). Reasons guiding the choice of the SC route were concerns about repeated hospital day-care (72%), greater autonomy with SC injections (38.7%) and economic considerations (21.5%). Reasons associated with choosing to maintain the IV route were worries about a lack of follow-up (72.1%), the absence of medical assistance during the SC injection (61.2%), maintaining social relationships with other patients developed at the hospital (40.5%), lower frequency of injection (32.9%), fear of adverse events (27.7%) and fear of SC injections (17.9%). Patients reject the SC switch from the IV route of tocilizumab and abatacept mainly because of fears about the unknown SC route, while those who accept it find it more convenient

Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres

Background: In a context of therapeutic inertia, the French Society of Rheumatology (SFR) published its first recommendations on gout in 2020, which were deliberately simple and concise. The objectives of the study were to determine the profile of patients referred to French gout-expert centres, and to examine the results of their management and the factors leading to those results. Methods: Three hundred patients attending a first visit for gout management in three French referral centres were retrospectively and randomly included in this multicentre observational study. Visits were performed at baseline (M0) and scheduled for month 6 (M6), month 12 (M12), and month 24 (M24). Results: Patients were 81% male and had a mean age 62.2 ± 15.2 years. Management followed French recommendations after the baseline visit in 94.9% of cases. SU levels were below 6.0 mg/dL in 59.4% of patients at M6, 67.9% at M12, and 78.6% at M24, with increasing clinical improvement (i.e., flare decrease) over 2 years of follow-up. At M24, 50% of patients were treated with allopurinol (313 ± 105 mg/d), which exceeded renal restrictions of doses in 61.5% of them, and 48.2% received febuxostat (84 ± 36 mg/d). The need for a sufficient dosage of ULT was the only predictive factor found for successful achievement of SU levels < 6.0 mg/dL at a given visit. Conclusions: Simple application of gout-management guidelines is feasible in clinical practice and is efficient, with a majority of patients achieving SU targets and clinical improvement

Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment

International audienceObjective To investigate the cutaneous tolerance of febuxostat in gouty patients with skin intolerance to allopurinol. Methods We identified all gouty patients who had sequentially received allopurinol and febuxostat in the rheumatology departments of 4 university hospitals in France and collected data from hospital files using a predefined protocol. Patients who had not visited the prescribing physician during at least 2 months after febuxostat prescription were excluded. The odds ratio (OR) for skin reaction to febuxostat in patients with a cutaneous reaction to allopurinol versus no reaction was calculated. For estimating the 95% confidence interval (95% CI), we used the usual Wald method and a bootstrap method. Results In total, 113 gouty patients had sequentially received allopurinol and febuxostat; 12 did not visit the prescribing physician after febuxostat prescription and were excluded. Among 101 patients (86 males, mean age 61 ± 13.9 years), 2/22 (9.1%) with a history of cutaneous reactions to allopurinol showed skin reactions to febuxostat. Two of 79 patients (2.5%) without a skin reaction to allopurinol showed skin intolerance to febuxostat. The ORs were not statistically significant with the usual Wald method (3.85 [95% CI 0.51–29.04]) or bootstrap method (3.86 [95% CI 0.80–18.74]). Conclusion The risk of skin reaction with febuxostat seems moderately increased in patients with a history of cutaneous adverse events with allopurinol. This moderate increase does not support the cross-reactivity of the two drug